What were the results from the Bruckner cardiothoracic study?

• A. Significant reduction in time to achieve hemostasis.
• B. Significant reduction in postoperative chest tube output.
• C. Significant reduction in postoperative blood transfusions.
• D. Significant reduction in time to achieve hemostasis; significant reduction in postoperative chest tube output; significant reduction in postoperative blood transfusions.

Answer: (D)

The main idea here is that a hemostatic intervention in cardiothoracic surgery is valued for multiple meaningful clinical outcomes, not just one. In the Bruckner cardiothoracic study, using the hemostatic agent produced significant improvements across three key measures: bleeding stopped more quickly, there was less postoperative drainage through chest tubes, and fewer patients required blood transfusions. Each of these outcomes reflects important benefits—quicker control of bleeding reduces overall blood loss and exposure to potential complications; lower chest tube output indicates less postoperative bleeding and fluid accumulation; fewer transfusions decrease risks, costs, and resource use. Seeing significant improvements in all three areas provides a stronger, more comprehensive picture of benefit than a single outcome alone, which is why the result indicating all three reductions is the best answer.